Advertisement
Canada markets close in 1 hour 50 minutes
  • S&P/TSX

    22,192.27
    +85.19 (+0.39%)
     
  • S&P 500

    5,254.68
    +6.19 (+0.12%)
     
  • DOW

    39,805.06
    +44.98 (+0.11%)
     
  • CAD/USD

    0.7389
    +0.0016 (+0.22%)
     
  • CRUDE OIL

    82.97
    +1.62 (+1.99%)
     
  • Bitcoin CAD

    96,025.53
    +3,021.12 (+3.25%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,242.90
    +30.20 (+1.36%)
     
  • RUSSELL 2000

    2,124.35
    +10.00 (+0.47%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • NASDAQ

    16,382.42
    -17.10 (-0.10%)
     
  • VOLATILITY

    13.04
    +0.26 (+2.03%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • CAD/EUR

    0.6841
    +0.0036 (+0.53%)
     

Datametrex Announces Increase in Normal Course Issuer Bid

Toronto, Ontario--(Newsfile Corp. - September 27, 2022) - Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTCQB: DTMXF) (the "Company" or "Datametrex") is pleased to announce that the TSX Venture Exchange (the "Exchange") has accepted a notice filed by Datametrex AI Limited of its intention to increase the number of common shares ("Shares") to be purchased for cancellation under the Company's Normal Course Issuer Bid (the "Bid") previously announced on June 2, 2022.

The notice provides that the Company may, during the 12-month period ending June 7, 2023, purchase up to an aggregate 34,789,603 Shares in total, being approximately ten percent (10%) of the total number of Shares outstanding as of June 2, 2022. To date, a total of 17,807,500 Shares have been purchased for cancellation under the NCIB. The price which the Company will pay for any such Shares will be the prevailing market price at the time of acquisition. The actual number of Shares which may be purchased pursuant to the Bid and the timing of any such purchases will be determined by management of the Company. Purchases under the Bid will be made from time to time by PI Financial Corp., Vancouver B.C., on behalf of the Company.

All Share purchases will be made on the open market through the facilities of the Exchange and will be purchased for cancellation. The funding for any purchase pursuant to the Bid will be financed out of the working capital of the Company.

ADVERTISEMENT

The Board of Directors believes the underlying value of the Company may not be reflected in the current market price of its Shares. As a result, depending upon future price movements and other factors, the Board believes the purchase of the Shares would be an appropriate use of corporate funds and in the best interests of the Company and its shareholders. Furthermore, the purchases are expected to benefit all persons who continue to hold Shares by increasing their equity interest in the Company if the repurchased Shares are cancelled.

Datametrex believes the Bid is a flexible tool and part of Datametrex' overall capital allocation program and objectives, while generating value for shareholders. Decisions regarding any future repurchases will depend on certain factors, such as market conditions, share price and other opportunities to invest capital for growth. Datametrex may elect to suspend or discontinue the Bid at any time, in accordance with applicable laws and policies of the Exchange.

"The Company believes the increased purchase of shares will greatly impact return to our shareholders and further increase shareholder value. Management greatly values our shareholders continued support as we expand our operations and business in AI, EV, and Telehealth. We are excited to share more developments very soon and look forward to the future growth of Datametrex!" said Marshall Gunter, CEO of the Company.

About Datametrex

Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning. Datametrex' mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. For additional information on Datametrex and other corporate information, please visit the Company's website at www.datametrex.com.

For further information:

Investor Relations & Communications

Priya Monique Atwal, Director of Communications
Email: investors@datametrex.com
Tel: 416-901-5611 x 204

Marshall Gunter, CEO
Email: mgunter@datametrex.com
Tel: 514-295-2300

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

All statements included in this press release that address activities, events, or developments that the Company expects, believes, or anticipates will or may occur in the future are forward-looking statements, including statements regarding the Bid. These forward-looking statements involve numerous assumptions made by the Company based on its experience, perception of historical trends, current conditions, expected future developments and other factors it believes are appropriate in the circumstances. In addition, these statements involve substantial known and unknown risks and uncertainties that contribute to the possibility that the predictions, forecasts, projections, and other forward-looking statements will prove inaccurate, certain of which are beyond the Company's control. Except as required by law, the Company does not undertake to revise or update these forward-looking statements after the date hereof or revise them to reflect the occurrence of future unanticipated events.

###

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/138500